PDF Cover

Fertility Services Market

The market for Fertility Services was estimated at $42.2 billion in 2024; it is anticipated to increase to $75.5 billion by 2030, with projections indicating growth to around $123 billion by 2035.

Report ID:DS1807004
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Life Science Technology
Fertility Services
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Fertility Services Market Outlook

Revenue, 2024

$42.2B

Forecast, 2034

$111B

CAGR, 2025 - 2034

10.2%

The Fertility Services industry revenue is expected to be around $46.5 billion in 2025 and expected to showcase growth with 10.2% CAGR between 2025 and 2034. The Fertility Services market maintains a strong position because infertility rates continue to rise while people delay having children and society becomes more accepting of assisted reproductive technology. The healthcare industry depends on hospitals and fertility clinics to deliver most of their services because these organizations together serve 87.0% of the market through their combined reproductive health offerings. The main revenue source of this environment consists of IVF Procedures because they produced $24.75 billion in sales during 2024 while patients continue to seek better in vitro fertilization methods and diagnostic tools which improve treatment outcomes. The sector maintains its strategic value for healthcare systems and patients because it continues to innovate and because it provides insurance coverage in specific markets and because it attracts more patients who seek fertility treatment abroad.

The Fertility Services division provides patients with various infertility treatments and reproductive health solutions which include diagnostic evaluations and ovulation induction and in vitro fertilization (IVF) and intrauterine insemination and donor programs and fertility preservation services through egg freezing. The services provide solutions for various medical needs which include treating complicated cases of male and female infertility as well as supporting individuals who choose to become single parents and same sex couples and cancer patients who want to protect their ability to have children in the future. The current market trends which create demand for IVF services involve the combination of genetic screening with preimplantation testing during IVF procedures and the implementation of data based treatment methods for individualized care and the expansion of digital healthcare services for distant patient monitoring and counseling. The combination of these new developments has transformed Fertility Services into a service which delivers patient centered results that match the changing requirements of people who need secure reproductive healthcare.

Fertility Services market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2024-2034
Fertility Services Market Outlook

Market Key Insights

  • The Fertility Services market is projected to grow from $42.2 billion in 2024 to $111 billion in 2034. This represents a CAGR of 10.2%, reflecting rising demand across Assisted Reproductive Technology (ART) Services, Fertility Diagnostics Services, and Egg and Sperm Cryopreservation Services.

  • The market competition exists between Apollo Hospitals Enterprise Ltd. and Care Fertility Group Ltd. and Carolinas Fertility Institute which operate as its leading industry participants.

  • The Fertility Services market shows its highest market share through U.S. and Germany which will experience CAGR growth rates of 7.4% to 10.7% during 2024 to 2030.

  • Our analysis predicts that India, Brazil and Mexico will experience the most significant growth among emerging markets at a combined annual rate of 9.8% to 12.8%.

  • The Fertility Services market will experience $2 billion growth until 2030 because of the increasing adoption of Assisted Reproductive Technology.

  • The Fertility Services market will experience a $69.2 billion growth expansion from 2024 to 2034 while manufacturers will focus on specific market region's which will result in increased market dominance.

  • The market for fertility services will experience a 164% growth from 2024 to 2034 because people are delaying their pregnancies and medical technology has improved fertility treatment methods.

fertility services market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Fertility Services - Country Share Analysis

Opportunities in the Fertility Services

North American couples who have high incomes and experience infertility or genetic diseases now choose to obtain fertility services which span across international borders for surrogate pregnancy and genetic screening and detailed legal agreements. The global surrogacy market has also reached $6.58 billion in revenue and experts predict it will expand to $13.12 billion during the next decade at a 12.2% annual growth rate. The potential for growth exists through integrated surrogacy programs which unite accredited clinics with legal advisors and financing partners. The procedure within Fertility Services which will experience the most significant expansion in North America will be genomics enabled surrogacy services.

Growth Opportunities in North America and Asia-Pacific

The main providers of fertility services in North America consist of dedicated fertility clinics which direct patients to hospitals for complex care needs. The market includes three main segments which consist of fertility clinics and hospitals that provide referral services and complex care and surrogacy centers and digital platforms which offer reproductive services to specific patient groups. The top available opportunities involve creating integrated assisted reproductive technology systems which unite IVF procedures with egg preservation services and genetic testing under employer backed insurance programs that use telehealth to monitor reproductive health. The clinic network competition with independent centers requires clinics to establish their unique value through clear achievement reports and patient focused IVF and sperm donation services and data based medical treatment approaches. The main factors which drive this trend include people delaying their decision to have children and health insurance companies now covering IVF procedures and men becoming more aware of their fertility issues and public policies which support surrogate parenting and multiple family's.
The Asia Pacific region bases its fertility services on big hospitals which perform initial disease detection and treat the first cases of infertility but new fertility clinics now serve patients in urban region's and medical tourism destinations and surrogacy centers operate under rules to provide limited services. The company has three main business opportunities which include offering different service levels that connect urban IVF services to secondary city facilities and creating financial plans for middle class patients and developing digital education programs that teach people about assisted reproduction and egg preservation. The market competition exists because local healthcare providers operate independently which allows international and regional businesses to grow their market share through hospital clinic alliances and their ability to deliver uniform medical care and their complete reproductive health services that include sperm donation and genetic testing. The main factors which drive this trend include increasing infertility rates because of lifestyle changes and rising consumer spending power and specific market based fertility support programs and patients who choose to access better fertility services through international medical travel.

Market Dynamics and Supply Chain

01

Driver: Rising global infertility prevalence combined with expanding awareness and acceptance of reproductive technologies

One of the primary drivers of the fertility services market is also the growing prevalence of infertility alongside increasing awareness and acceptance of ART. Infertility rates continue to rise globally due to delayed parenthood, changing lifestyles, environmental exposure, and higher incidence of conditions such as polycystic ovary syndrome and endometriosis, significantly expanding the potential patient pool. In parallel, social attitudes toward fertility treatments are also evolving, with reduced stigma and greater openness toward medical intervention for conception. Increased public education, digital fertility platforms, and proactive engagement by clinics are also encouraging early diagnosis and treatment adoption. Acceptance of ART among diverse patient groups-including older couples, single individuals, and same-sex couples-has also broadened demand for services such as IVF, ICSI, egg freezing, and donor programs. Together, these factors are also driving higher procedure volumes, improving clinic utilization rates, and supporting sustained revenue growth across both mature and emerging fertility care markets.
Continuous technological innovation in ART and reproductive diagnostics is also a key driver of market growth. Breakthroughs such as improved cryopreservation techniques, time-lapse embryo imaging, AI-enhanced embryo selection systems, and expanded genetic screening tools are also increasing success rates and patient confidence. These innovations help clinics optimize treatment protocols and personalize care, leading to better clinical outcomes and higher patient satisfaction. As a result, demand increases among patients seeking effective, outcome-oriented solutions, strengthening revenue streams and encouraging uptake of premium, tech-enabled fertility services.
02

Restraint: High Treatment Costs and Limited Insurance Coverage Discourage Patient Access and Reduce Service Uptake

The significant cost burden of fertility treatments combined with sparse or inadequate insurance reimbursement constrains patient access, lowering overall demand. In many regions, procedures like IVF can cost thousands per cycle, deterring middle-income patients and leading to delayed or foregone treatment. Limited coverage also pushes prospective patients toward less expensive alternatives or out-of-pocket financing, directly dampening revenue growth and slowing new patient inflows in price-sensitive markets. Example - In the U.S., where many plans exclude IVF coverage, a large portion of patients self-finance cycles, reducing repeat treatments and suppressing clinic utilization rates compared to countries with comprehensive coverage, such as parts of Europe.
03

Opportunity: Digital-first artificial insemination Fertility Services and counseling platforms targeting underserved secondary cities across Latin America and Rising demand for IVF-based Fertility Services among career-focused women in urban Asia-Pacific metropolitan regions

The absence of specialized Fertility Services in secondary cities throughout Latin America drives users to seek platforms which offer artificial insemination services together with telehealth fertility coaching and home based monitoring capabilities. The worldwide artificial insemination market produces $7.80 billion in revenue but experts predict it will expand to $13.30 billion during 2030 with a 9.3% annual growth rate. The availability of this technology varies between different geographic region's. The deployment of satellite centers with low capital expenses together with AI based triage systems and subscription based treatment options enables healthcare providers to access additional patient demographics. The mid priced artificial insemination Fertility Services in new urban region's of developing cities will show faster growth than the complete market expansion.
Women from urban region's across the Asia Pacific region choose to postpone their pregnancy timing which leads them to seek Fertility Services that combine IVF procedures with egg preservation and genetic evaluation through digital fertility centers. The worldwide IVF market currently produces $24.75 billion in revenue which experts predict will reach $44.08 billion during the next decade at a 10.1% annual growth rate. The treatment remains inaccessible to most people who live in Tier 2 and Tier 3 cities. The IVF centric Fertility Services segment will experience its fastest growth in these metropolitan clusters because providers who perform price localization and assisted reproductive technology implementation and employer fertility benefit partnerships will achieve the highest success rates.
04

Challenge: Regulatory Complexity and Ethical Constraints Hinder Service Expansion and Delay Market Innovation Adoption

Stringent regulations, ethical debates, and evolving legal frameworks in key geographies slow market expansion and technological deployment. Policies governing embryo storage, genetic testing, donor anonymity, and cross-border reproductive care vary widely, creating compliance burdens for providers and increasing operational costs. These restrictions can delay clinic openings, limit service portfolios, and deter investment, ultimately inhibiting competitive differentiation and slowing revenue growth in tightly regulated jurisdictions. Example - In countries with restrictive embryo research laws or limitations on surrogacy, clinics may be unable-to offer advanced ART techniques, reducing their competitive appeal and pushing patients to travel abroad, fragmenting demand and weakening local market revenue.

Supply Chain Landscape

1

Diagnostic Fertility Services

Apollo Hospitals Enterprise Ltd.Carolinas Fertility Institute
2

IVF Fertility Services

Care Fertility Group Ltd.City Fertility
3

Cryobank Egg Freezing

Fertility Associates LimitedCare Fertility Group Ltd.
4

Patient End Users

Fertility ClinicsAssisted Reproductive Technology Centers
Fertility Services - Supply Chain

Use Cases of Fertility Services in Assisted Reproductive Technology (ART) & Egg

Assisted Reproductive Technology (ART) Services : Assisted Reproductive Technology (ART) services represent a core application within the fertility services market, primarily centered on advanced procedures like IVF and intracytoplasmic sperm injection (ICSI) to help individuals and couples conceive when conventional methods fail. IVF remains the dominant and most widely used ART service in fertility clinics worldwide, offering high success rates through embryo culture, genetic testing, and cryopreservation solutions. Fertility clinics and specialized ART facilities lead end-user adoption due to their focused expertise, personalized treatment plans, and integration of cutting-edge technologies such as AI-enhanced embryo selection and automated lab systems. Key market players-including CooperSurgical, Vitrolife, Ferring Pharmaceuticals, Merck KGaA, and FUJIFILM Irvine Scientific-drive growth through technological innovation, extensive service portfolios, and global clinic networks that strengthen their competitive positions and improve patient outcomes.
Fertility Diagnostics Services : Fertility Diagnostics Services refers to diagnostic applications within the broader fertility services market that help assess reproductive potential and guide treatment decisions. This includes hormone profiling, ovulation detection, semen analysis, and genetic screening, primarily used by fertility clinics, hospitals, and diagnostic labs to support IVF, IUI and other ART procedures. Leaders such as Abbott Laboratories, Swiss Precision Diagnostics (Clearblue) and CooperSurgical dominate with advanced testing platforms and broad distribution, while companies like Vitrolife and Thermo Fisher Scientific leverage lab-grade assays and analytics for precision diagnostics that improve treatment outcomes and clinical workflows.
Egg and Sperm Cryopreservation Services : Egg and Sperm Cryopreservation Services-an application within the fertility services market-focuses on long-term preservation of reproductive cells for future use in assisted reproductive technologies like IVF or ICSI. Fertility clinics and cryobanks are the primary end-users, leveraging advanced vitrification and storage protocols to ensure high post-thaw viability and patient success rates. Leading players such as California Cryobank, Cryos International, Vitrolife, CooperSurgical, and IVI-RMA Global distinguish themselves through innovation, extensive clinic networks, quality control, and comprehensive service offerings that drive market growth and patient trust.

Recent Developments

The latest advancements in the field of Fertility Services showcase a trend towards utilizing cutting edge technologies in the industry. The swift advancements in ART such as In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI) have brought about a transformation in fertility care. These developments have expanded the options for couples facing fertility challenges by enabling them to pursue parenthood more effectively consequently leading to an increase in demand, within the market.

June 2025 : Carolinas Fertility Institute entered a strategic partnership with Femasys to introduce the FemaSeed infertility treatment across its clinic network. This collaboration expanded CFI’s fertility service portfolio by offering a minimally invasive, lower-cost first-line treatment option prior to IVF. The move is aimed at improving patient access, increasing early-stage treatment volumes, and strengthening CFI’s clinical differentiation within the competitive U.S. fertility services market.
April 2025 : Care Fertility Group announced the appointment of Michael Henry as Chief Executive Officer to accelerate growth and enhance patient-centric fertility care delivery. The leadership transition is intended to support operational scalability, service quality improvements, and expansion across its clinics in the UK, Ireland, Spain, and the U.S. The change reflects Care Fertility’s focus on strengthening management capabilities to sustain long-term market expansion.

Impact of Industry Transitions on the Fertility Services Market

As a core segment of the Life Science Technology industry, the Fertility Services market develops in line with broader industry shifts. Over recent years, transitions such as Upsurge in Assisted Reproductive Technology adoption and Shift towards Personalized Patient Experience have redefined priorities across the Life Science Technology sector, influencing how the Fertility Services market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Upsurge in Assisted Reproductive Technology adoption

The Fertility Services market experiences growing ART adoption which transforms the market through IVF and ICSI and donor egg and sperm programs that now treat infertility at a rapid pace. The market for Fertility Services will experience a $2 billion growth expansion through 2030 because of increasing worldwide infertility cases and enhanced treatment outcomes and growing public understanding of fertility treatments. The market will achieve its core revenue base through ART because this structural change will occur. The global Fertility Services market will experience providers who expand their ART capabilities and optimize laboratory equipment and develop individualized treatment options will gain control of most market share while strengthening their market position and creating new benchmarks for healthcare accessibility and quality.
02

Shift towards Personalized Patient Experience

The shift towards personalized patient experience is becoming a significant driver in the fertility services market, as patients increasingly expect customized treatment pathways rather than standardized protocols. Clinics are adopting patient-specific stimulation plans, genetic profiling, hormone monitoring, and AI-driven embryo selection to improve clinical outcomes and patient confidence. Personalized counseling, emotional support programs, and digital fertility monitoring tools further enhance patient engagement and retention. This tailored care model improves success rates, reduces cycle failures, and encourages repeat treatment cycles, directly supporting higher clinic revenues, stronger brand differentiation, and long-term patient loyalty in an increasingly competitive fertility care landscape.